- Home
- ORIC vs NVGS Comparison
ORIC vs NVGS Comparison
Compare ORIC & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- NVGS
- Stock Information
- Founded
- ORIC 2014
- NVGS 1997
- Country
- ORIC United States
- NVGS United Kingdom
- Employees
- ORIC N/A
- NVGS N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- NVGS Marine Transportation
- Sector
- ORIC Health Care
- NVGS Consumer Discretionary
- Exchange
- ORIC Nasdaq
- NVGS Nasdaq
- Market Cap
- ORIC 1.1B
- NVGS 1.1B
- IPO Year
- ORIC 2020
- NVGS N/A
- Fundamental
- Price
- ORIC $14.19
- NVGS $14.73
- Analyst Decision
- ORIC Strong Buy
- NVGS Strong Buy
- Analyst Count
- ORIC 8
- NVGS 3
- Target Price
- ORIC $16.57
- NVGS $22.33
- AVG Volume (30 Days)
- ORIC 1.6M
- NVGS 271.1K
- Earning Date
- ORIC 11-11-2025
- NVGS 11-05-2025
- Dividend Yield
- ORIC N/A
- NVGS 1.35%
- EPS Growth
- ORIC N/A
- NVGS 12.51
- EPS
- ORIC N/A
- NVGS 1.26
- Revenue
- ORIC N/A
- NVGS $566,889,000.00
- Revenue This Year
- ORIC N/A
- NVGS $3.68
- Revenue Next Year
- ORIC N/A
- NVGS N/A
- P/E Ratio
- ORIC N/A
- NVGS $11.79
- Revenue Growth
- ORIC N/A
- NVGS 1.19
- 52 Week Low
- ORIC $3.90
- NVGS $10.55
- 52 Week High
- ORIC $14.93
- NVGS $17.53
- Technical
- Relative Strength Index (RSI)
- ORIC 71.68
- NVGS 30.54
- Support Level
- ORIC $13.85
- NVGS $15.16
- Resistance Level
- ORIC $14.93
- NVGS $15.77
- Average True Range (ATR)
- ORIC 0.81
- NVGS 0.34
- MACD
- ORIC 0.35
- NVGS -0.17
- Stochastic Oscillator
- ORIC 85.29
- NVGS 1.88
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.